132 related articles for article (PubMed ID: 22334268)
1. Basic science for the clinician 54: CD5.
Sigal LH
J Clin Rheumatol; 2012 Mar; 18(2):83-8. PubMed ID: 22334268
[TBL] [Abstract][Full Text] [Related]
2. CD5: a safeguard against autoimmunity and a shield for cancer cells.
Dalloul A
Autoimmun Rev; 2009 Feb; 8(4):349-53. PubMed ID: 19041428
[TBL] [Abstract][Full Text] [Related]
3. B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells.
Jin G; Hamaguchi Y; Matsushita T; Hasegawa M; Le Huu D; Ishiura N; Naka K; Hirao A; Takehara K; Fujimoto M
J Allergy Clin Immunol; 2013 Jun; 131(6):1674-82. PubMed ID: 23534976
[TBL] [Abstract][Full Text] [Related]
4. CD5-positive B cells at the crossroads of B cell malignancy and nonorgan-specific autoimmunity.
Youinou P; Pers JO; Jamin C; Lydyard PM
Pathol Biol (Paris); 2000 Jul; 48(6):574-6. PubMed ID: 10965537
[TBL] [Abstract][Full Text] [Related]
5. The paradox of CD5-expressing B cells in systemic lupus erythematosus.
Youinou P; Renaudineau Y
Autoimmun Rev; 2007 Dec; 7(2):149-54. PubMed ID: 18035326
[TBL] [Abstract][Full Text] [Related]
6. Increased numbers of CD5+ B lymphocytes with a regulatory phenotype in spondylarthritis.
Cantaert T; Doorenspleet ME; Francosalinas G; Paramarta JE; Klarenbeek PL; Tiersma Y; van der Loos CM; De Vries N; Tak PP; Baeten DL
Arthritis Rheum; 2012 Jun; 64(6):1859-68. PubMed ID: 22231660
[TBL] [Abstract][Full Text] [Related]
7. B lymphocytes on the front line of autoimmunity.
Youinou P; Hillion S; Jamin C; Pers JO; Saraux A; Renaudineau Y
Autoimmun Rev; 2006 Mar; 5(3):215-21. PubMed ID: 16483922
[TBL] [Abstract][Full Text] [Related]
8. The antiphospholipid syndrome as a model for B cell-induced autoimmune diseases.
Youinou P; Renaudineau Y
Thromb Res; 2004; 114(5-6):363-9. PubMed ID: 15507266
[TBL] [Abstract][Full Text] [Related]
9. B lymphocytes are required for development and treatment of autoimmune diseases.
Youinou P; Jamin C; Pers JO; Berthou C; Saraux A; Renaudineau Y
Ann N Y Acad Sci; 2005 Jun; 1050():19-33. PubMed ID: 16014517
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice.
Morshed SR; Mannoor K; Halder RC; Kawamura H; Bannai M; Sekikawa H; Watanabe H; Abo T
Eur J Immunol; 2002 Sep; 32(9):2551-61. PubMed ID: 12207339
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T cells as central regulators of both autoimmunity and B cell malignancy in New Zealand Black mice.
Scaglione BJ; Salerno E; Gala K; Pan M; Langer JA; Mostowski HS; Bauer S; Marti G; Li Y; Tsiagbe VK; Raveche ES
J Autoimmun; 2009 Feb; 32(1):14-23. PubMed ID: 19022624
[TBL] [Abstract][Full Text] [Related]
12. Intravascular large B-cell lymphoma: the CD5 antigen is expressed by a subset of cases.
Khalidi HS; Brynes RK; Browne P; Koo CH; Battifora H; Medeiros LJ
Mod Pathol; 1998 Oct; 11(10):983-8. PubMed ID: 9796727
[TBL] [Abstract][Full Text] [Related]
13. Regulatory B cells in autoimmune diseases: how do they work?
Lemoine S; Morva A; Youinou P; Jamin C
Ann N Y Acad Sci; 2009 Sep; 1173():260-7. PubMed ID: 19758160
[TBL] [Abstract][Full Text] [Related]
14. Estrogen induces normal murine CD5+ B cells to produce autoantibodies.
Ansar Ahmed S; Dauphinée MJ; Montoya AI; Talal N
J Immunol; 1989 Apr; 142(8):2647-53. PubMed ID: 2467934
[TBL] [Abstract][Full Text] [Related]
15. CD5- dendritic epidermal T cells are derived from CD5+ precursor cells.
Payer E; Kutil R; Stingl G
Eur J Immunol; 1994 Jun; 24(6):1317-22. PubMed ID: 7515810
[TBL] [Abstract][Full Text] [Related]
16. CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire.
Casali P; Notkins AL
Immunol Today; 1989 Nov; 10(11):364-8. PubMed ID: 2482031
[TBL] [Abstract][Full Text] [Related]
17. Expression and regulation of CD5 on in vitro activated human B cells.
Freedman AS; Freeman G; Whitman J; Segil J; Daley J; Levine H; Nadler LM
Eur J Immunol; 1989 May; 19(5):849-55. PubMed ID: 2472277
[TBL] [Abstract][Full Text] [Related]
18. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
[TBL] [Abstract][Full Text] [Related]
19. Role of B-1a cells in autoimmunity.
Duan B; Morel L
Autoimmun Rev; 2006 Jul; 5(6):403-8. PubMed ID: 16890894
[TBL] [Abstract][Full Text] [Related]
20. The role of B lymphocytes in the progression from autoimmunity to autoimmune disease.
Salinas GF; Braza F; Brouard S; Tak PP; Baeten D
Clin Immunol; 2013 Jan; 146(1):34-45. PubMed ID: 23202542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
